Web Flow - Login to access your portal

Philadelphia Site Cold Chain Capacity Expansion

PCI Pharma Services is pleased to announce investment in a considerable expansion of our onsite Cold Chain storage at our Philadelphia site.

Cold Chain at PCI Philadelphia

An additional 500 pallet spaces have been added, increasing the onsite 2-8°C refrigerated storage at our commercial packaging center of excellence to more than 1,300 pallets. The 450,000 square foot site features contract packaging services for Over-the-Counter medicines, Ethical pharmaceuticals, Medical Devices, as well as Animal Health therapies.

It has been estimated Biologics represent more than 37% of all drugs in pipeline development,” states Ken Richardson, PCI Vice President of Global Engineering. “That certainly mirrors the trends we are seeing towards growth in parenteral delivery forms and medicines requiring strict end-to-end Cold Chain logistics. On average, we launch over 50 products a year and a large proportion of those are drugs with needs for end-to-end Cold Chain. We continue to invest considerably in both areas – adding infrastructure to meet growing demand for vial labeling, syringe labeling and assembly, as well as labeling and assembly of autoinjectors and pens, complemented by investing in ample site storage for these medicines needing refrigerated or frozen conditions. We anticipate these needs will increase considerably as these pipeline medicines reach commercialization, in addition to anticipated growth associated with development of biosimilars. PCI is well positioned to support clients in both areas.

Our investment in Cold Chain infrastructure and parenterals packaging at the Philadelphia site continues a series of investments in this fast-growing market segment. PCI’s European based Hay-on-Wye facility recently announced the installation of a state-of-the-art multipurpose custom engineered parenteral labeling unit manufactured by Marchesini capable of supporting a variety of injectable delivery forms such as vials, syringes, and autoinjectors. PCI’s Rockford, Illinois site also recently announced installation of cryogenic storage in support of the growing cell and gene therapy market, another market segment requiring strict temperature controlled activities that often range from -140°C to -196°C. We features multiple sites across its global supply network with strictly monitored controlled temperature conditions to meet exacting client requirements, ranging from +25°C down to -196°C.

Posted on Categories News

Leave a Reply

Your email address will not be published. Required fields are marked *

12 + fifteen =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...